Starling Oncology, Inc. Current Liabilities
Starling Oncology, Inc. (STLN) had Current Liabilities of $94.94 million as of 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Current
us-gaap:LiabilitiesCurrent · last filed 2026-08-06
- 2026-06-30: Liabilities, Current $94.94M.
- 2026-03-31: Liabilities, Current $79.35M.
- 2025-12-31: Liabilities, Current $70.96M.
- 2025-09-30: Liabilities, Current $65.58M.
| Period end | Liabilities, Current | Liabilities, Current as first filed |
|---|---|---|
| 2026-06-30 | $94.94M 10-Q · filed 2026-08-06 | |
| 2026-03-31 | $79.35M 10-Q · filed 2026-05-07 | |
| 2025-12-31 | $70.96M 10-Q · filed 2026-08-06 | |
| 2025-09-30 | $65.58M 10-Q · filed 2025-11-13 | |
| 2025-06-30 | $64.78M 10-Q · filed 2025-08-13 | |
| 2025-03-31 | $59.54M 10-Q · filed 2025-05-14 | |
| 2024-12-31 | $52.22M 10-K · filed 2026-03-12 | |
| 2024-09-30 | $46.76M 10-Q · filed 2024-11-13 | |
| 2024-06-30 | $35.10M 10-Q · filed 2024-08-13 | |
| 2024-03-31 | $45.77M 10-Q · filed 2024-05-14 | |
| 2023-12-31 | $34.79M 10-K · filed 2025-03-26 | |
| 2023-09-30 | $32.39M 10-Q · filed 2023-11-08 | |
| 2023-06-30 | $33.51M 10-Q · filed 2023-08-09 | |
| 2023-03-31 | $30.09M 10-Q · filed 2023-05-10 | |
| 2022-12-31 | $29.72M 10-K · filed 2024-03-28 | |
| 2022-09-30 | $32.85M 10-Q · filed 2022-11-09 | |
| 2022-06-30 | $36.13M 10-Q · filed 2022-08-09 | |
| 2022-03-31 | $31.52M 10-Q · filed 2022-05-10 | |
| 2021-12-31 | $29.80M 10-K · filed 2023-03-16 | |
| 2021-09-30 | $3.63M 10-Q/A · filed 2021-12-14 | |
| 2021-06-30 | $2.52M 10-Q · filed 2021-08-16 | |
| 2021-03-31 | $171.57K 10-Q · filed 2021-05-28 | |
| 2020-12-31 | $28.61M 10-K · filed 2022-03-11 | $267.55K 10-K · filed 2021-03-30 |
| 2020-09-30 | $196.93K 10-K/A · filed 2021-05-24 | |
| 2020-06-30 | $130.60K 10-K/A · filed 2021-05-24 | |
| 2020-03-31 | $390.93K 10-K/A · filed 2021-05-24 | |
| 2019-12-31 | $27.30K 10-K/A · filed 2021-12-14 |